In spite of harsh censorship by the powers that be
Post# of 72440
...Ivermectin has been shown in many legitimate studies outside U.S. as an effective tool at the inception of contracting Covid-19...
Ivermectin will be no threat to Brilacidin's financial opportunities...because of the DIRE NEED for Brilacidin's 3 mechanisms to save those who have moderate to severe Covid-19...
...IMO we will all learn VERY SHORTLY the extension of GMU Brilacidin test results reflected in the Clinical Trial results...at which point....the real fun begins...T
ps. Calls for DATA from the Military symposium are misleading...those who produced the data...OWN THE DATA...and IPIX...cannot release data without permission. Only exception is Data paid for by IPIX...and only limited to what they contracted for. GMU, Rutgers and others studying Brilacidin OWN THE DATA and do not just give it away...its proprietary to them (again, unless they wish to "give away" their work. (which work and data they use to get grants for themselves) ...